111in-cs-1008
mAbexperimentalImaging agent
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2010 (NCT01220999)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
TNFRSF10B inhibitor
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 111-indium
Oral
No
Parenteral
No
Topical
No
Also known as
- 111in-cs-1008
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01220999 | Phase 1 | Oct 1, 2010 | Austin Health, Daiichi Sankyo, Ludwig Institute for Cancer Research |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Austin Health | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Daiichi Sankyo | For profit | 1 | 0 | 1 | 2010 |
| Ludwig Institute for Cancer Research | Academic/Hospital | 1 | 1 | 1 | 2010 |
3 organizations
Page 1 / 1